Navigation Links
Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:9/20/2011

NEW YORK, Sept. 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0617109/Prosthetic-Heart-Valves---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global prosthetic heart valves market. The report provides market landscape, competitive landscape and market trends information on the prosthetic heart valves market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the prosthetic heart valves market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, Edwards Lifesciences Corporation, St. Jude Medical and Sorin Group.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the prosthetic heart valves market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the prosthetic heart valves market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global prosthetic heart valves market and the factors shaping it.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 GlobalData Report Guidance 9

3 Disease Overview: Valvular Heart Disease 10

3.1 Types of Valvular Heart Disease 10

3.2 Symptoms and Diagnosis of Valvular Heart Disease 10

3.3 Treatment of Valvular Heart Disease 10

3.4 Epidemiology 11

4 Device Overview: Prosthetic Heart Valves 12

4.1 Prosthetic Heart Valve-Based Treatment of Valvular Heart Disease 12

4.2 Prosthetic Heart Valves: Market Segmentation 12

4.2.1 Mechanical Heart Valves 13

4.2.2 Tissue Heart Valves 13

4.2.3 Transcatheter Heart Valves 13

5 Prosthetic Heart Valves: Global Market Characterization 14

5.1 Prosthetic Heart Valves Market, Global, Revenue ($m), Historic, 2003?2010 14

5.2 Prosthetic Heart Valves Market, Global, Revenue ($m), Forecast, 2010?2017 15

5.3 Prosthetic Heart Valves, Key Trends 16

5.3.1 Launch and Faster Adoption of Transcatheter Heart Valves 16

5.3.2 Increasing Shift from Mechanical Heart Valves to Tissue Heart Valves 16

5.4 Opportunities and Unmet Needs 17

5.4.1 Opportunity: Substantial Under-treated Population Provides Significant Market Potential to Companies 17

5.4.2 Unmet Need: Risks Associated with Implantation to Restrain Growth of the Market for Prosthetic Heart Valves 17

5.5 Prosthetic Heart Valves, Market Dynamics 17

5.5.1 Market Drivers 17

5.5.2 Market Restraints 21

6 Prosthetic Heart Valves Market: Segment Analysis 23

6.1 Transcatheter Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 23

6.2 Transcatheter Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 24

6.3 Transcatheter Heart Valves, Market Dynamics 25

6.3.1 Market Drivers 25

6.3.2 Market Restraint 25

6.4 Tissue Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 26

6.5 Tissue Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 27

6.6 Tissue Heart Valves, Market Dynamics 28

6.6.1 Market Driver 28

6.6.2 Market Restraint 28

6.7 Mechanical Heart Valves Market, Revenue ($m), Historic, 2003 – 2010 29

6.8 Mechanical Heart Valves Market, Revenue ($m), Forecast, 2010 – 2017 30

6.9 Mechanical Heart Valves, Market Dynamics 31

6.9.1 Market Driver 31

6.9.2 Market Restraint 31

7 Prosthetic Heart Valves Market, by Country, Revenue ($m), 2003 – 2017 32

7.1 Prosthetic Heart Valves Market, the US, Revenue ($m), By Segment, Historic, 2003 – 2010 32

7.2 Prosthetic Heart Valves Market, the US, Revenue ($m), By Segment, Forecast, 2010 – 2017 33

7.3 Prosthetic Heart Valves Market, Canada, Revenue ($m), By Segment, Historic, 2003 – 2010 34

7.4 Prosthetic Heart Valves Market, Canada, Revenue ($m), By Segment, Forecast, 2010 – 2017 35

7.5 Prosthetic Heart Valves Market, the UK, Revenue ($m), By Segment, Historic, 2003 – 2010 36

7.6 Prosthetic Heart Valves Market, the UK, Revenue ($m), By Segment, Forecast, 2010 – 2017 37

7.7 Prosthetic Heart Valves Market, Germany, Revenue ($m), By Segment, Historic, 2003 – 2010 38

7.8 Prosthetic Heart Valves Market, Germany, Revenue ($m), By Segment, Forecast, 2010 – 2017 39

7.9 Prosthetic Heart Valves Market, France, Revenue ($m), By Segment, Historic, 2003 – 2010 40

7.10 Prosthetic Heart Valves Market, France, Revenue ($m), By Segment, Forecast, 2010 – 2017 41

7.11 Prosthetic Heart Valves Market, Italy, Revenue ($m), By Segment, Historic, 2003 – 2010 42

7.12 Prosthetic Heart Valves Market, Italy, Revenue ($m), By Segment, Forecast, 2010 – 2017 43

7.13 Prosthetic Heart Valves Market, Spain, Revenue ($m), By Segment, Historic, 2003 – 2010 44

7.14 Prosthetic Heart Valves Market, Spain, Revenue ($m), By Segment, Forecast, 2010 – 2017 45

7.15 Prosthetic Heart Valves Market, Japan, Revenue ($m), By Segment, Historic, 2003–2010 46

7.16 Prosthetic Heart Valves Market, Japan, Revenue ($m), By Segment, Forecast, 2010 – 2017 47

7.17 Prosthetic Heart Valves Market, China, Revenue ($m), By Segment, Historic, 2003 – 2010 48

7.18 Prosthetic Heart Valves Market, China, Revenue ($m), By Segment, Forecast, 2010 – 2017 49

7.19 Prosthetic Heart Valves Market, India, Revenue ($m), By Segment, Historic, 2003 – 2010 50

7.20 Prosthetic Heart Valves Market, India, Revenue ($m), By Segment, Forecast, 2010 – 2017 51

7.21 Prosthetic Heart Valves Market, Australia, Revenue ($m), By Segment, Historic, 2003 – 2010 52

7.22 Prosthetic Heart Valves Market, Australia, Revenue ($m), By Segment, Forecast, 2010 – 2017 53

7.23 Prosthetic Heart Valves Market, Brazil, Revenue ($m), By Segment, Historic, 2003 – 2010 54

7.24 Prosthetic Heart Valves Market, Brazil, Revenue ($m), By Segment, Forecast, 2010 – 2017 55

8 Prosthetic Heart Valves Market: Competitive Landscape 56

8.1 Prosthetic Heart Valves Market, Key Company Share (%), 2010 56

8.2 Prosthetic Heart Valves Market, Key Market Participants 57

8.2.1 Edwards Lifesciences Corporation 57

8.2.2 Medtronic, Inc. 62

8.2.3 St. Jude Medical, Inc. 66

8.2.4 Sorin Group 69

9 Prosthetic Heart Valves Market: Key Marketed Products 73

9.1 SAPIEN XT Transcatheter Heart Valve (Edwards Lifesciences Corporation) 73

9.1.1 Product Description 73

9.2 Features and Benefits 73

9.3 Carpentier-Edwards PERIMOUNT Magna Mitral Ease Heart Valve (Edwards Lifesciences Corporation) 73

9.3.1 Product Description 73

9.3.2 Features and Benefits 73

9.4 3f Aortic Bioprosthesis (Medtronic, Inc.) 74

9.4.1 Product Description 74

9.4.2 Features and Benefits 74

9.5 Trifecta Valve (St. Jude Medical) 74

9.5.1 Product Description 74

9.5.2 Features and Benefits 74

9.6 CarboMedics Standard Aortic Valve (Sorin Group) 75

9.6.1 Product Description 75

9.6.2 Features and Benefits 75

9.7 Perceval S (Sorin Group) 75

9.7.1 Product Description 75

9.7.2 Features and Benefits 75

10 Prosthetic Heart Valves Market: Strategic Pipeline Assessment 76

10.1 Pipeline Products Assessment for Prosthetic Heart Valves by Development Stage, Global, 2010 76

10.2 Transcatheter Heart Valves, Pipeline Analysis 77

10.2.1 18 Fr Percutaneous Aortic Valve System 78

10.2.2 22 Fr Percutaneous Aortic Valve System 79

10.2.3 Acurate TA Aortic Valve Replacement System 80

10.2.4 CoreValve ReValving System 81

10.2.5 Edwards SAPIEN Transcatheter Heart Valve 87

10.2.6 Edwards SAPIEN XT Valve - NovaFlex Delivery System 89

10.2.7 Elast-Eon Polymer Heart Valve 90

10.2.8 JenaValve Transapical TAVI System 90

10.2.9 Lotus Valve System 92

10.2.10 Transapical AVR System 93

10.3 Tissue Heart Valves, Pipeline Analysis 95

10.3.1 ATS 3F Enable Sutureless Valve 96

10.3.2 Carpentier-Edwards PERIMOUNT Magna Ease Aortic Heart Valve 97

10.3.3 dCELL Heart Valve 99

10.3.4 Freedom Solo 99

10.3.5 Mitroflow Aortic Pericardial Heart Valve 101

10.3.6 Perceval S Aortic Heart Valve 103

10.3.7 Synergraft Xenograft Heart Valve 105

10.3.8 Ventor Embracer 106

10.4 Mechanical Heart Valves, Pipeline Analysis 107

10.4.1 ATS Open Pivot Heart Valve-ForceField 107

11 Prosthetic Heart Valves Market: Deals Landscape 108

11.1 Key Acquisition Deals 108

11.1.1 Medtronic Completes Acquisition of ATS Medical 108

11.1.2 Medtronic Acquires CoreValve from Sofinnova Partners, Apax Partners, HealthCap and Maverick Capital 109

11.1.3 ATS Medical Acquires 3F Therapeutics 110

11.1.4 Vascutek Acquires Bioprosthetic Heart Valve Business of Kohler Chemie 110

11.2 Key Partnership Deals 111

11.2.1 On-X Life Technologies Enters into Licensing Agreement with Cleveland Clinic 111

11.2.2 Sorin Signs Distribution Agreement with Japan Lifeline 112

11.2.3 Medtronic Enters Into Licensing Agreement with Arbor Surgical Technologies 112

11.3 Key Venture Financing Deals 113

11.3.1 CardiAQ Valve Technologies Secures $6.5m in Series A Financing Round 114

11.3.2 Direct Flow Medical Secures $40m in Third Round of Financing 114

11.3.3 Symetis Secures $21.2m in Venture Financing 114

12 Appendix 115

12.1 Market Definitions 115

12.1.1 Prosthetic Heart Valves 115

12.2 Abbreviations 116

12.3 Sources 117

12.4 Research Methodology 117

12.4.1 Secondary Research 117

12.4.2 Primary Research 118

12.4.3 Models 118

12.4.4 Forecasts 118

12.4.5 Expert Panel 119

12.5 GlobalData Consulting 119

12.6 Contact Us 119

12.7 Disclaimer 119

List of Tables

Table 1: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003–2010 14

Table 2: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010–2017 15

Table 3: Population Aged 65 and Above (million), Global, 2004-2010 18

Table 4: Prevalence of Aortic Stenosis, the US, 2004 19

Table 5: Tissue Heart Valves Replacement, Global, Procedures, 2010–2016 20

Table 6: Cardiac Valve Procedures, Inpatient Hospital Reimbursements based on MS-DRGs, US 21

Table 7: Transcatheter Heart Valves Market, Global, Revenue ($m), 2003–2010 23

Table 8: Transcatheter Heart Valves Market, Global, Revenue ($m), 2010–2017 24

Table 9: Tissue Heart Valves Market, Global, Revenue ($m), 2003–2010 26

Table 10: Tissue Heart Valves Market, Global, Revenue ($m), 2010–2017 27

Table 11: Mechanical Heart Valves Market, Global, Revenue ($m), 2003–2010 29

Table 12: Mechanical Heart Valves Market, Global, Revenue ($m), 2010–2017 30

Table 13: Prosthetic Heart Valves Market, the US, Revenue ($m), 2003–2010 32

Table 14: Prosthetic Heart Valves Market, the US, Revenue ($m), 2010–2017 33

Table 15: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2003–2010 34

Table 16: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2010–2017 35

Table 17: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2003–2010 36

Table 18: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2010–2017 37

Table 19: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2003–2010 38

Table 20: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2010–2017 39

Table 21: Prosthetic Heart Valves Market, France, Revenue ($m), 2003–2010 40

Table 22: Prosthetic Heart Valves Market, France, Revenue ($m), 2010–2017 41

Table 23: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2003–2010 42

Table 24: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2010–2017 43

Table 25: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2003–2010 44

Table 26: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2010–2017 45

Table 27: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2003–2010 46

Table 28: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2010–2017 47

Table 29: Prosthetic Heart Valves Market, China, Revenue ($m), 2003–2010 48

Table 30: Prosthetic Heart Valves Market, China, Revenue ($m), 2010–2017 49

Table 31: Prosthetic Heart Valves Market, India, Revenue ($m), 2003–2010 50

Table 32: Prosthetic Heart Valves Market, India, Revenue ($m), 2010–2017 51

Table 33: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2003–2010 52

Table 34: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2010–2017 53

Table 35: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2003–2010 54

Table 36: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2010–2017 55

Table 37: Prosthetic Heart Valves Market, Key Company Shares ($m), 2010 56

Table 38: Edwards Lifesciences Corporation, Prosthetic Heart Valves, Marketed Products 58

Table 39: Edwards Lifesciences Corporation, Prosthetic Heart Valves, Pipeline Products 58

Table 40: Medtronic Inc., Prosthetic Heart Valves, Marketed Products 62

Table 41: Medtronic Inc., Prosthetic Heart Valves, Pipeline Products 63

Table 42: St. Jude Medical Inc., Prosthetic Heart Valves, Marketed Products 67

Table 43: St. Jude Medical Inc., Prosthetic Heart Valves, Pipeline Products 67

Table 44: Sorin S.p.A., Prosthetic Heart Valves, Marketed Products 70

Table 45: Sorin S.p.A., Prosthetic Heart Valves, Pipeline Products 70

Table 46: SAPIEN XT Transcatheter Heart Valve, Features and Benefits 73

Table 47: Carpentier-Edwards PERIMOUNT Magna Mitral Ease, Features and Benefits 73

Table 48: 3f Aortic Bioprosthesis, Features and Benefits 74

Table 49: Trifecta Valve, Features and Benefits 74

Table 50: CarboMedics Standard Aortic Valve, Features and Benefits 75

Table 51: Perceval S, Features and Benefits 75

Table 52: Transcatheter Heart Valves Market, Pipeline Products 77

Table 53: 18 Fr Percutaneous Aortic Valve System- Clinical Trial 78

Table 54: 22 Fr Percutaneous Aortic Valve System- Clinical Trial 79

Table 55: Acurate TA Aortic Valve Replacement System- Clinical Trial 80

Table 56: CoreValve ReValving System- Clinical Trial I 81

Table 57: CoreValve ReValving System- Clinical Trial II 82

Table 58: CoreValve ReValving System- Clinical Trial III 83

Table 59: CoreValve ReValving System- Clinical Trial IV 84

Table 60: CoreValve ReValving System- Clinical Trial V 85

Table 61: CoreValve ReValving System- Clinical Trial VI 86

Table 62: Edwards SAPIEN Transcatheter Heart Valve- Clinical Trial I 87

Table 63: Edwards SAPIEN Transcatheter Heart Valve- Clinical Trial II 88

Table 64: Edwards SAPIEN XT Valve - NovaFlex Delivery System- Clinical Trial I 89

Table 65: Edwards SAPIEN XT Valve - NovaFlex Delivery System- Clinical Trial II 90

Table 66: JenaValve Transapical TAVI System Clinical Trial I 91

Table 67: JenaValve Transapical TAVI System Clinical Trial II 92

Table 68: Lotus Valve System Clinical Trial 93

Table 69: Transapical AVR System Clinical Trial 94

Table 70: Tissue Heart Valves Market, Pipeline Products 95

Table 71: ATS 3F Enable Sutureless Valve- Clinical Trial I 96

Table 72: ATS 3F Enable Sutureless Valve- Clinical Trial II 97

Table 73: Carpentier-Edwards PERIMOUNT Magna Ease Aortic Heart Valve- Clinical Trial 98

Table 74: Freedom Solo Clinical Trial I 99

Table 75: Freedom Solo Clinical Trial II 100

Table 76: Freedom Solo Clinical Trial III 101

Table 77: Mitroflow Aortic Pericardial Heart Valve Clinical Trial I 102

Table 78: Mitroflow Aortic Pericardial Heart Valve Clinical Trial II 103

Table 79: Perceval S Aortic Heart Valve Clinical Trial I 104

Table 80: Perceval S Aortic Heart Valve Clinical Trial II 105

Table 81: Ventor Embracer Clinical Trial 106

Table 82: Mechanical Heart Valves Market, Pipeline Products 107

Table 83: Prosthetic Heart Valves Market, Acquisition Deals, 2005 – 2010 108

Table 84: Prosthetic Heart Valves Market, Partnership Deals, 2005 – 2010 111

Table 85: Prosthetic Heart Valves Market, Venture Financing Deals, 2005 – 2010 113

List of Figures

Figure 1: Prosthetic Heart Valves, Market Segmentation 12

Figure 2: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003–2010 14

Figure 3: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010–2017 15

Figure 4: Population Aged 65 and Above (million), Global, 2004-2010 18

Figure 5: Prevalence of Aortic Stenosis, the US, 2004 19

Figure 6: Tissue Heart Valves Market, Global, Procedures, 2010–2016 20

Figure 7: Transcatheter Heart Valves Market, Global, Revenue ($m), 2003–2010 23

Figure 8: Transcatheter Heart Valves Market, Global, Revenue ($m), 2010–2017 24

Figure 9: Tissue Heart Valves Market, Global, Revenue ($m), 2003–2010 26

Figure 10: Tissue Heart Valves Market, Global, Revenue ($m), 2010–2017 27

Figure 11: Mechanical Heart Valves Market, Global, Revenue ($m), 2003–2010 29

Figure 12: Mechanical Heart Valves Market, Global, Revenue ($m), 2010–2017 30

Figure 13: Prosthetic Heart Valves Market, the US, Revenue ($m), 2003–2010 32

Figure 14: Prosthetic Heart Valves Market, the US, Revenue ($m), 2010–2017 33

Figure 15: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2003–2010 34

Figure 16: Prosthetic Heart Valves Market, Canada, Revenue ($m), 2010–2017 35

Figure 17: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2003–2010 36

Figure 18: Prosthetic Heart Valves Market, the UK, Revenue ($m), 2010–2017 37

Figure 19: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2003–2010 38

Figure 20: Prosthetic Heart Valves Market, Germany, Revenue ($m), 2010–2017 39

Figure 21: Prosthetic Heart Valves Market, France, Revenue ($m), 2003–2010 40

Figure 22: Prosthetic Heart Valves Market, France, Revenue ($m), 2010–2017 41

Figure 23: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2003–2010 42

Figure 24: Prosthetic Heart Valves Market, Italy, Revenue ($m), 2010–2017 43

Figure 25: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2003–2010 44

Figure 26: Prosthetic Heart Valves Market, Spain, Revenue ($m), 2010–2017 45

Figure 27: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2003–2010 46

Figure 28: Prosthetic Heart Valves Market, Japan, Revenue ($m), 2010–2017 47

Figure 29: Prosthetic Heart Valves Market, China, Revenue ($m), 2003–2010 48

Figure 30: Prosthetic Heart Valves Market, China, Revenue ($m), 2010–2017 49

Figure 31: Prosthetic Heart Valves Market, India, Revenue ($m), 2003–2010 50

Figure 32: Prosthetic Heart Valves Market, India, Revenue ($m), 2010–2017 51

Figure 33: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2003–2010 52

Figure 34: Prosthetic Heart Valves Market, Australia, Revenue ($m), 2010–2017 53

Figure 35: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2003–2010 54

Figure 36: Prosthetic Heart Valves Market, Brazil, Revenue ($m), 2010–2017 55

Figure 37: Prosthetic Heart Valves Market, Key Company Shares (%), 2010 56

Figure 38: Prosthetic Heart Valves Market, Edwards Lifesciences Corporation, SWOT Analysis 59

Figure 39: Prosthetic Heart Valves Market, Medtronic Inc., SWOT Analysis 63

Figure 40: Prosthetic Heart Valves Market, St. Jude Medical Inc., SWOT Analysis 67

Figure 41: Prosthetic Heart Valves Market, Sorin S.p.A., SWOT Analysis 71

Figure 42: Prosthetic Heart Valves Market, Pipeline Products, By Development Stage 76

Companies Mentioned

Edwards Lifesciences Corporation

Medtronic, Inc.

St. Jude Medical, Inc.

Sorin Group

To order this report:

Cardiovascular Devices Industry: Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Cardiovascular Devices Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. VA Studies Advanced Prosthetic Arm
2. Reportlinker Adds Orthopedic Prosthetics - A World Market Review
3. HDT Develops Robotic Arm Technology for DARPAs Revolutionizing Prosthetics 2009 Program
4. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
5. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
6. Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US
7. New Program Makes Prosthetics Available to All Haitian Children Who Lost Limbs in Earthquake
8. Reportlinker Adds Canadian Dental Market Overview & Dentist Survey 2010 (Implants, Prosthetics, Imaging & CAD/CAM)
9. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
10. Reportlinker Adds European Market for Dental Prosthetics and CAD/CAM Devices 2011
11. Reportlinker Adds Global Orthopedic Prosthetics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... FARMINGDALE, N.Y., Feb. 9, 2016  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... second quarter and the first half of fiscal ... --> --> Highlights ...
(Date:2/9/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... systems, today announced its financial results for the second quarter of ... Financial Results for the ... Revenue for the second quarter of fiscal ... period last year.  Cash receipts from customers for the second quarter ...
(Date:2/9/2016)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... year financial results on Tuesday, February 23, 2016, after ... host a live audio webcast immediately following the announcement ... quarter and full year 2015 financial results and provide ... financial results. www.jazzpharmaceuticals.com .  Please connect to ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Gout is like no other joint ... is often severe, with intense swelling and redness. It is triggered by the crystallization ... older adults are the most susceptible, according to the February 2016 issue of Harvard ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team ... 2016. FHU President Joe Wiley made the announcement Monday night, Feb. 8, prior to ... 2003 graduate of FHU and the creator of GO! Camp, has been named director. ...
(Date:2/10/2016)... ... February 10, 2016 , ... It’s that time of year when most people ... the Interscholastic Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison Forest ... cast aside. , That’s why one of her first decisions when her IAAM two-year ...
Breaking Medicine News(10 mins):